Tech Company Financing Transactions
TMRW Life Sciences Funding Round
TMRW Life Sciences secured a $12 million Series A funding round on 5/30/2019. Investors included Special Situations Life Sciences Fund and private investors.
Transaction Overview
Company Name
Announced On
5/30/2019
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Special Situations Life Sciences Fund (Lead Investor)
Proceeds Purpose
This capital will help us refine our technology, further expand our board and executive leadership team and make our technology available to fertility clinics worldwide.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
250 Hudson St. 701
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Overview
TMRW is revolutionizing in vitro fertilization with the first automated and robotic cryo-management platform devoted to IVF. TMRW's cryo-management platform features 100% physical and digital chain-of-custody and continuous local and remote monitoring.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alan Murray
Chief Executive Officer
Joshua Abram
Chief Information Officer
Amit Gupta
Chief Medical Officer
Jeffrey Port
Chief Operating Officer
William Garbarini
Chief Operating Officer
Melanie Goldey
VP - Bus. Development
Lori Batta
VP - Engineering
Christina Raad
VP - Finance
Lexi Henkel
VP - Product Management
Benjamin Harlow
VP - Regulatory Affairs
Michael Collins
Browse more venture capital transactions:
Prev: 5/30/2019: ChargeAfter venture capital transaction
Next: 5/30/2019: AttackIQ venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs